Preclinical studies in various human and murine cancer models (HCT116, SKOV-3, B16-F10) showed notable tumor uptake (2.20–4.84% ID/g at 6 h), mediated by transcobalamin II (TCII) receptors. The gene discussed is TCN2; the disease is neoplasm.